{"chunk_id": "medquad__chunk_4553", "source": "medquad", "text": "nt with certain anticancer drugs and/or radiation therapy may cause therapy -related AML (t-AML) or therapy-related MDS (t-MDS). The risk of these therapy-related myeloid diseases depends on the total dose of the anticancer drugs used and the radiation dose and treatment field. Some patients also have an inherited risk for t-AML and t-MDS. These therapy-related diseases usually occur within 7 years after treatment, but are rare in children.\",CancerGov,Childhood Acute Myeloid Leukemia and Other M"}